HuGE Literature Finder
Records
1
-
4
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel. The pharmacogenomics journal 2021 Jan . Vivaldi Caterina, Crucitta Stefania, Catanese Silvia, Cucchiara Federico, Arrigoni Elena, Pecora Irene, Rofi Eleonora, Fornaro Lorenzo, Salani Francesca, Massa Valentina, Vasile Enrico, Morganti Riccardo, Danesi Romano, Del Re Marz |
Impact of genetic variants of ABCB1, APOB, CAV1, and NAMPT on susceptibility to pancreatic ductal adenocarcinoma in Chinese patients. Molecular genetics & genomic medicine 2020 Apr e1226. Li Baohuan, Zhang Chuanzhen, Wang Jingjing, Zhang Meijuan, Liu Changhong, Chen Zipi |
ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance? Gastroenterology research and practice 2014 2014 414931. Pang Li, Word Beverly, Xu Joshua, Wang Honggang, Hammons George, Huang Shiew-Mei, Lyn-Cook Bever |
Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome. Cancer 2011 Feb 117 (4): 744-51. Tanaka Motofumi, Okazaki Taro, Suzuki Hideo, Abbruzzese James L, Li Dongh |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 17, 2022
- Content source: